JohnSundyMDPhD

Clinical Trials

• Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout Start of enrollment: 2004 Dec 01

  Completed

  Phase 2

• Nitric Oxide, LPS and the Pathogenesis of Asthma Phase II Start of enrollment: 2003 Apr 01

  Terminated

  Phase 1

• Genetics of Asthma - Bronchoscopy Studies Start of enrollment: 2007 Sep 01

  Terminated

  Phase 1

• Nitric Oxide, LPS and the Pathogenesis of Asthma Phase 1 Start of enrollment: 2003 May 01

  Completed

• Differential Gene Expression in Lung and Peripheral Blood After Inhaled Allergen Challenge Start of enrollment: 2006 Oct 01

  Terminated

  Phase 1

• Role of TLR4 in Environmental Asthma Start of enrollment: 2001 Sep 01

  Completed

  Phase 1

• Role of RhuMab-E25 in Reducing Exhaled Nitric Oxide (NO) in Allergic Asthma Start of enrollment: 2002 Oct 01

  Completed

  Phase 3

• Strategies for Enhancing Mucosal Immunity to Influenza Vaccine Start of enrollment: 2011 Apr 01

  Completed

  Early Phase 1

• Long-acting Beta Agonist Step Down Study Start of enrollment: 2012 Mar 01

  Completed

  Phase 4

• Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout Start of enrollment: 2012 Jan 01

  Unknown status

  Phase 2

• Effect of Positive Airway Pressure on Reducing Airway Reactivity in Patients With Asthma (CPAP) Start of enrollment: 2012 Jul 01

  Completed

  Not Applicable

• Join now to see all